The Editor’s Roundtable: Cardiac Resynchronization Therapy

      This CME activity is sponsored by an educational grant from Boston Scientific, Natick, Massachusetts.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Hunt S.A.
        • Abraham W.T.
        • Chin M.H.
        • Feldman A.M.
        • Francis G.S.
        • Ganiats T.G.
        • Konstam M.
        • Mancini D.M.
        • Michl K.
        • Oates J.A.
        • Rahko P.S.
        • Silver M.A.
        • Stevenson L.W.
        • Yancy C.W.
        • Antman E.M.
        • Smith S.C.
        • Adams C.D.
        • Anderson J.L.
        • Faxon D.P.
        • Fuster V.
        • Halperin J.L.
        • Hiratzka L.F.
        • Hunt S.A.
        • Jacobs A.K.
        • Nishimura R.
        • Ornato J.P.
        • Riegel B.
        ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult—summary article.
        Circulation. 2005; 112: 1825-1852
        • Cleland J.G.F.
        • Daubert J.-C.
        • Erdmann E.
        • Freemantle N.
        • Gras D.
        • Kappenberger L.
        • Tavazzi L.
        • Cardiac Resynchronization—Heart Failure (CARE-HF) Study Investigators
        The effect of cardiac resynchronization on morbidity and mortality in heart failure.
        N Engl J Med. 2005; 352: 1539-1549
        • Bristow M.R.
        • Saxon L.A.
        • Boehmer J.
        • Krueger S.
        • Kass D.A.
        • De Marco T.
        • Carson P.
        • DiCarlo L.
        • DeMets D.
        • White B.G.
        • DeVries D.W.
        • Feldman A.M.
        Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.
        N Engl J Med. 2004; 350: 2140-2150
        • Bardy G.H.
        • Lee K.L.
        • Mark D.B.
        • Poole J.E.
        • Packer D.L.
        • Boineau R.
        • Domanski M.
        • Troutman C.
        • Anderson J.
        • Johnson G.
        • et al.
        • Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators
        Amiodarone or an implantable cardioverter- defibrillator for congestive heart failure.
        N Engl J Med. 2005; 352: 225-237
        • Abraham W.T.
        • Young J.B.
        • León A.R.
        • Adler S.
        • Bank A.J.
        • Hall S.A.
        • Lieberman R.
        • Bing Liem L.
        • O’Connell J.B.
        • Schroeder J.S.
        • Wheelan K.R.
        • Multicenter InSync ICD II Study Group
        Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.
        Circulation. 2004; 110: 2864-2868